Drawing for DRIVEN BY OUR PROMISE

USPTO serial 88646217

DRIVEN BY OUR PROMISE

Reviewed by CopyMark Law Group

Reg. 7157624Status 700Registered
Filing date
Status date
Registration date
Sep 5, 2023
Examiner
PEREZ, STEVEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DRIVEN BY OUR PROMISE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST. NW, SUITE 400WASHINGTON, DC 20007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing medical and scientific research information in the field of health and pharmaceuticals; Medical laboratory services, namely, scientific testing and screening services for testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Scientific research; product research and development services, including scientific, medical, pharmaceutical and blood products research and development services; pharmaceutical research and development; research and development of vaccines and medicines; Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, blood conditions, blood illnesses and blood diseases, including via a global computer network; Providing medical and scientific research information in the field of clinical trials and pharmaceuticalsACTIVE—
044Providing medical information and treatment information in the field of health; medical services; medical testing and screening services for diagnostic or treatment purposes; medical testing of human blood plasma for diagnostic or treatment purposes; collection of human blood plasma; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matterACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 5, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 31, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 8, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 29, 2023IUAFUSE AMENDMENT FILED—
Jun 29, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 21, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 20, 2023EX5GSOU EXTENSION 5 GRANTED—
Jan 20, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 5, 2023EXT5SOU EXTENSION 5 FILED—
Jan 5, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2022EX4GSOU EXTENSION 4 GRANTED—
Jun 22, 2022EXT4SOU EXTENSION 4 FILED—
Jun 22, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2022EX3GSOU EXTENSION 3 GRANTED—
Jan 5, 2022EXT3SOU EXTENSION 3 FILED—
Jan 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 21, 2021EXT2SOU EXTENSION 2 FILED—
Jun 21, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2021EX1GSOU EXTENSION 1 GRANTED—
Jan 5, 2021EXT1SOU EXTENSION 1 FILED—
Jan 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 26, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 26, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2020ALIEASSIGNED TO LIE—
Mar 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2020DOCKASSIGNED TO EXAMINER—
Oct 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 11, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance